Financial Insights
Funding Insights
$56M
Most recent funding amount
1
Number of funding rounds
Stock Symbol
CRSP
Financial Scoops
Aug 8 2024
Earnings
Project
CRISPR Therapeutics has recently released 2024 Q2 report with the following insight: Developing and manufacturing complex gene and cell therapies is extremely costly and time-consuming. The regulatory pathway for these novel therapies is still evolving and uncertain. Scaling up manufacturing for cell therapies while maintaining quality and consistency is challenging. For in vivo gene editing, achieving efficient delivery to target tissues beyond the liver remains difficult. Long-term safety and durability of effect for gene editing therapies is still being established.
Aug 8 2024
Earnings
Project
CRISPR Therapeutics has recently released 2024 Q2 report with the following insight: CRISPR Therapeutics aims to apply CRISPR/Cas9 gene editing technology to develop transformative therapies for both rare and common diseases. They seek to advance their pipeline of product candidates through clinical development and ultimately to market. The company is working to innovate continuously, developing next-generation editing approaches through their CRISPR-X research team. They aim to expand the applications of their technology through strategic partnerships.
Funding Data
Dive into CRISPR Therapeutics’ funding data, including significant investment rounds, funding trends, total capital raised, and key backers, to understand CRISPR Therapeutics’ investor confidence and growth trajectory.
Funding Data | | | |
|---|
| Oct 18, 2016 | Stock Issuance/Offering | $56M | -- |
See more funding data
Get a detailed breakdown of CRISPR Therapeutics' estimated departmental budgets, including marketing, finance, human resources, IT, and more, to gain insight into CRISPR Therapeutics' resource allocation and financial priorities
-
Marketing Budget
-
Finance Budget
-
IT Budget
-
HR Budget
See full department budgets
Frequently Asked Questions Regarding CRISPR Therapeutics Financial Insights
What are the most recent funding rounds that CRISPR Therapeutics has completed, and what were the funding rounds? CRISPR Therapeutics has recently completed 1 funding rounds: Stock Issuance/Offering on Oct 18, 2016. What is the total amount of funding CRISPR Therapeutics has raised to date? CRISPR Therapeutics has raised a total of $56M in funding to date. How many funding rounds has CRISPR Therapeutics completed? CRISPR Therapeutics has completed 1 funding rounds. How much funding did CRISPR Therapeutics raise in its most recent funding round? CRISPR Therapeutics raised $56M in its most recent funding round. Who are the lead investors in CRISPR Therapeutics's latest funding round? The lead investor in CRISPR Therapeutics's latest funding round was --. What are CRISPR Therapeutics's most significant expenses, and how does it allocate its budget? Significant expenses include marketing, HR, finance ad IT. Which was the largest funding round in CRISPR Therapeutics's history? The largest funding round in CRISPR Therapeutics's history was $56M. See more information about CRISPR Therapeutics
